NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
NantHealth Inc (NASDAQ: NH)
NH Technical Analysis
4
As on 9th Jun 2023 NH STOCK Price closed @ 0.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.62 & Buy for SHORT-TERM with Stoploss of 0.90 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NHSTOCK Price
Open | 0.94 | Change | Price | % |
High | 0.96 | 1 Day | 0.04 | 4.40 |
Low | 0.94 | 1 Week | -0.43 | -31.16 |
Close | 0.95 | 1 Month | -0.64 | -40.25 |
Volume | 1295 | 1 Year | -0.06 | -5.94 |
52 Week High 5.70 | 52 Week Low 0.24 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
NH Daily Charts |
NH Intraday Charts |
Whats New @ Bazaartrend |
NH Free Analysis |
|
NH Important Levels Intraday
RESISTANCE | 0.99 |
RESISTANCE | 0.98 |
RESISTANCE | 0.97 |
RESISTANCE | 0.96 |
SUPPORT | 0.94 |
SUPPORT | 0.93 |
SUPPORT | 0.92 |
SUPPORT | 0.91 |
NH Forecast May 2024
4th UP Forecast | 1.72 |
3rd UP Forecast | 1.47 |
2nd UP Forecast | 1.32 |
1st UP Forecast | 1.17 |
1st DOWN Forecast | 0.73 |
2nd DOWN Forecast | 0.58 |
3rd DOWN Forecast | 0.43 |
4th DOWN Forecast | 0.18 |
NH Weekly Forecast
4th UP Forecast | 1.39 |
3rd UP Forecast | 1.25 |
2nd UP Forecast | 1.16 |
1st UP Forecast | 1.08 |
1st DOWN Forecast | 0.82 |
2nd DOWN Forecast | 0.74 |
3rd DOWN Forecast | 0.65 |
4th DOWN Forecast | 0.51 |
NH Forecast2024
4th UP Forecast | 13.63 |
3rd UP Forecast | 9.56 |
2nd UP Forecast | 7.05 |
1st UP Forecast | 4.54 |
1st DOWN Forecast | -2.64 |
2nd DOWN Forecast | -5.15 |
3rd DOWN Forecast | -7.66 |
4th DOWN Forecast | -11.73 |
NantHealth Inc ( NASDAQ USA Symbol : NH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NH Other Details
Segment | EQ | |
Market Capital | 187784144.00 | |
Sector | Healthcare | |
Industry | Health Information Services | |
Offical website | > echo $website ; ?> |
NH Address
NH Latest News
NH Business Profile
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC. Address: 9920 Jefferson Boulevard, Culver City, CA, United States, 90232
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service